Immunological profile of a Plasmodium vivax AMA-1 N-terminus peptide-carbon nanotube conjugate in an infected Plasmodium berghei mouse model
We have covalently conjugated an N-terminus Plasmodium vivax apical membrane antigen-1 (AMA-1) peptide to functionalized carbon nanotubes (f-CNT). Immunological characterization of this molecular conjugate revealed that the immunogen-AMA-1 peptide was appropriately presented after being conjugated t...
- Autores:
- Tipo de recurso:
- Fecha de publicación:
- 2008
- Institución:
- Universidad del Rosario
- Repositorio:
- Repositorio EdocUR - U. Rosario
- Idioma:
- eng
- OAI Identifier:
- oai:repository.urosario.edu.co:10336/23447
- Acceso en línea:
- https://doi.org/10.1016/j.vaccine.2008.08.014
https://repository.urosario.edu.co/handle/10336/23447
- Palabra clave:
- Apical membrane antigen 1
Carbon nanotube
Drug carrier
Polyclonal antibody
Amino terminal sequence
Animal experiment
Animal model
Article
Bagg albino mouse
Conjugation
Controlled study
Drug delivery system
Drug structure
Female
Immune system
Immunogenicity
Malaria
Mouse
Nonhuman
Parasitemia
Plasmodium berghei
Plasmodium vivax
Priority journal
Alleles
Amino acid sequence
Animals
Cytokines
Drug delivery systems
Enzyme-linked immunosorbent assay
Female
Fluorescent antibody technique
Hla-dr antigens
Malaria
Malaria vaccines
Membrane proteins
Mice
Molecular sequence data
Nanotubes
Plasmodium berghei
Plasmodium vivax
Protozoan proteins
Apical membrane antigen 1 (ama-1)
Functionalized carbon nanotubes (f-cnt)
Synthetic vaccine delivery system
protozoan
mhc class ii
subunit
western
inbred balb c
electron
Antigens
Blotting
Genes
Mice
Microscopy
Vaccines
- Rights
- License
- Abierto (Texto Completo)
id |
EDOCUR2_c43845231b73e936fcb5e2281a497c7d |
---|---|
oai_identifier_str |
oai:repository.urosario.edu.co:10336/23447 |
network_acronym_str |
EDOCUR2 |
network_name_str |
Repositorio EdocUR - U. Rosario |
repository_id_str |
|
spelling |
0b3f2261-a522-4a91-ae3b-76200da750d0-10864ca35-5d05-418f-9e1e-6d745dabf423-10c194e2a-f1c6-4106-a89d-262d7d665683-1a66d3bf5-338f-463b-a488-32b0e6341cca-19e3ba9df-fe89-48fe-9521-cc8f452d56f5-1ed02648e-d655-4bbd-8d6e-90ad3efa4387-12020-05-26T00:02:05Z2020-05-26T00:02:05Z2008We have covalently conjugated an N-terminus Plasmodium vivax apical membrane antigen-1 (AMA-1) peptide to functionalized carbon nanotubes (f-CNT). Immunological characterization of this molecular conjugate revealed that the immunogen-AMA-1 peptide was appropriately presented after being conjugated to CNTs as well as being recognized by BALB/c polyclonal antibodies. Subsequent experiments lead us to assess the AMA-1 peptide alone, as well as the CNT-peptide conjugate regarding rodent malarial infection. Remarkably, the peptide effectively controlled and delayed Plasmodium berghei-challenged animals' parasitaemia. The peptide-CNT conjugate displayed similar immunological properties to the peptide alone by protecting or delaying malarial infection. The peptide presentation by f-CNT to the immune system thus constitutes a promising approach for synthetic malarial vaccine formulation since the immunogen peptide conformation is well preserved. © 2008 Elsevier Ltd. All rights reserved.application/pdfhttps://doi.org/10.1016/j.vaccine.2008.08.0140264410X13588745https://repository.urosario.edu.co/handle/10336/23447eng5873No. 465864VaccineVol. 26Vaccine, ISSN:0264410X, 13588745, Vol.26, No.46 (2008); pp. 5864-5873https://www.scopus.com/inward/record.uri?eid=2-s2.0-53449093079&doi=10.1016%2fj.vaccine.2008.08.014&partnerID=40&md5=f24cf4ad2c3fdb0f0fb8cc9ebd87a1a3Abierto (Texto Completo)http://purl.org/coar/access_right/c_abf2instname:Universidad del Rosarioreponame:Repositorio Institucional EdocURApical membrane antigen 1Carbon nanotubeDrug carrierPolyclonal antibodyAmino terminal sequenceAnimal experimentAnimal modelArticleBagg albino mouseConjugationControlled studyDrug delivery systemDrug structureFemaleImmune systemImmunogenicityMalariaMouseNonhumanParasitemiaPlasmodium bergheiPlasmodium vivaxPriority journalAllelesAmino acid sequenceAnimalsCytokinesDrug delivery systemsEnzyme-linked immunosorbent assayFemaleFluorescent antibody techniqueHla-dr antigensMalariaMalaria vaccinesMembrane proteinsMiceMolecular sequence dataNanotubesPlasmodium bergheiPlasmodium vivaxProtozoan proteinsApical membrane antigen 1 (ama-1)Functionalized carbon nanotubes (f-cnt)Synthetic vaccine delivery systemprotozoanmhc class iisubunitwesterninbred balb celectronAntigensBlottingGenesMiceMicroscopyVaccinesImmunological profile of a Plasmodium vivax AMA-1 N-terminus peptide-carbon nanotube conjugate in an infected Plasmodium berghei mouse modelarticleArtículohttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_6501Yandar, NubiaPastorin, GiorgiaPrato, MaurizioBianco, AlbertoPatarroyo, Manuel ElkinLozano, José Manuel10336/23447oai:repository.urosario.edu.co:10336/234472022-05-02 07:37:21.510716https://repository.urosario.edu.coRepositorio institucional EdocURedocur@urosario.edu.co |
dc.title.spa.fl_str_mv |
Immunological profile of a Plasmodium vivax AMA-1 N-terminus peptide-carbon nanotube conjugate in an infected Plasmodium berghei mouse model |
title |
Immunological profile of a Plasmodium vivax AMA-1 N-terminus peptide-carbon nanotube conjugate in an infected Plasmodium berghei mouse model |
spellingShingle |
Immunological profile of a Plasmodium vivax AMA-1 N-terminus peptide-carbon nanotube conjugate in an infected Plasmodium berghei mouse model Apical membrane antigen 1 Carbon nanotube Drug carrier Polyclonal antibody Amino terminal sequence Animal experiment Animal model Article Bagg albino mouse Conjugation Controlled study Drug delivery system Drug structure Female Immune system Immunogenicity Malaria Mouse Nonhuman Parasitemia Plasmodium berghei Plasmodium vivax Priority journal Alleles Amino acid sequence Animals Cytokines Drug delivery systems Enzyme-linked immunosorbent assay Female Fluorescent antibody technique Hla-dr antigens Malaria Malaria vaccines Membrane proteins Mice Molecular sequence data Nanotubes Plasmodium berghei Plasmodium vivax Protozoan proteins Apical membrane antigen 1 (ama-1) Functionalized carbon nanotubes (f-cnt) Synthetic vaccine delivery system protozoan mhc class ii subunit western inbred balb c electron Antigens Blotting Genes Mice Microscopy Vaccines |
title_short |
Immunological profile of a Plasmodium vivax AMA-1 N-terminus peptide-carbon nanotube conjugate in an infected Plasmodium berghei mouse model |
title_full |
Immunological profile of a Plasmodium vivax AMA-1 N-terminus peptide-carbon nanotube conjugate in an infected Plasmodium berghei mouse model |
title_fullStr |
Immunological profile of a Plasmodium vivax AMA-1 N-terminus peptide-carbon nanotube conjugate in an infected Plasmodium berghei mouse model |
title_full_unstemmed |
Immunological profile of a Plasmodium vivax AMA-1 N-terminus peptide-carbon nanotube conjugate in an infected Plasmodium berghei mouse model |
title_sort |
Immunological profile of a Plasmodium vivax AMA-1 N-terminus peptide-carbon nanotube conjugate in an infected Plasmodium berghei mouse model |
dc.subject.keyword.spa.fl_str_mv |
Apical membrane antigen 1 Carbon nanotube Drug carrier Polyclonal antibody Amino terminal sequence Animal experiment Animal model Article Bagg albino mouse Conjugation Controlled study Drug delivery system Drug structure Female Immune system Immunogenicity Malaria Mouse Nonhuman Parasitemia Plasmodium berghei Plasmodium vivax Priority journal Alleles Amino acid sequence Animals Cytokines Drug delivery systems Enzyme-linked immunosorbent assay Female Fluorescent antibody technique Hla-dr antigens Malaria Malaria vaccines Membrane proteins Mice Molecular sequence data Nanotubes Plasmodium berghei Plasmodium vivax Protozoan proteins Apical membrane antigen 1 (ama-1) Functionalized carbon nanotubes (f-cnt) Synthetic vaccine delivery system |
topic |
Apical membrane antigen 1 Carbon nanotube Drug carrier Polyclonal antibody Amino terminal sequence Animal experiment Animal model Article Bagg albino mouse Conjugation Controlled study Drug delivery system Drug structure Female Immune system Immunogenicity Malaria Mouse Nonhuman Parasitemia Plasmodium berghei Plasmodium vivax Priority journal Alleles Amino acid sequence Animals Cytokines Drug delivery systems Enzyme-linked immunosorbent assay Female Fluorescent antibody technique Hla-dr antigens Malaria Malaria vaccines Membrane proteins Mice Molecular sequence data Nanotubes Plasmodium berghei Plasmodium vivax Protozoan proteins Apical membrane antigen 1 (ama-1) Functionalized carbon nanotubes (f-cnt) Synthetic vaccine delivery system protozoan mhc class ii subunit western inbred balb c electron Antigens Blotting Genes Mice Microscopy Vaccines |
dc.subject.keyword.eng.fl_str_mv |
protozoan mhc class ii subunit western inbred balb c electron Antigens Blotting Genes Mice Microscopy Vaccines |
description |
We have covalently conjugated an N-terminus Plasmodium vivax apical membrane antigen-1 (AMA-1) peptide to functionalized carbon nanotubes (f-CNT). Immunological characterization of this molecular conjugate revealed that the immunogen-AMA-1 peptide was appropriately presented after being conjugated to CNTs as well as being recognized by BALB/c polyclonal antibodies. Subsequent experiments lead us to assess the AMA-1 peptide alone, as well as the CNT-peptide conjugate regarding rodent malarial infection. Remarkably, the peptide effectively controlled and delayed Plasmodium berghei-challenged animals' parasitaemia. The peptide-CNT conjugate displayed similar immunological properties to the peptide alone by protecting or delaying malarial infection. The peptide presentation by f-CNT to the immune system thus constitutes a promising approach for synthetic malarial vaccine formulation since the immunogen peptide conformation is well preserved. © 2008 Elsevier Ltd. All rights reserved. |
publishDate |
2008 |
dc.date.created.spa.fl_str_mv |
2008 |
dc.date.accessioned.none.fl_str_mv |
2020-05-26T00:02:05Z |
dc.date.available.none.fl_str_mv |
2020-05-26T00:02:05Z |
dc.type.eng.fl_str_mv |
article |
dc.type.coarversion.fl_str_mv |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
dc.type.coar.fl_str_mv |
http://purl.org/coar/resource_type/c_6501 |
dc.type.spa.spa.fl_str_mv |
Artículo |
dc.identifier.doi.none.fl_str_mv |
https://doi.org/10.1016/j.vaccine.2008.08.014 |
dc.identifier.issn.none.fl_str_mv |
0264410X 13588745 |
dc.identifier.uri.none.fl_str_mv |
https://repository.urosario.edu.co/handle/10336/23447 |
url |
https://doi.org/10.1016/j.vaccine.2008.08.014 https://repository.urosario.edu.co/handle/10336/23447 |
identifier_str_mv |
0264410X 13588745 |
dc.language.iso.spa.fl_str_mv |
eng |
language |
eng |
dc.relation.citationEndPage.none.fl_str_mv |
5873 |
dc.relation.citationIssue.none.fl_str_mv |
No. 46 |
dc.relation.citationStartPage.none.fl_str_mv |
5864 |
dc.relation.citationTitle.none.fl_str_mv |
Vaccine |
dc.relation.citationVolume.none.fl_str_mv |
Vol. 26 |
dc.relation.ispartof.spa.fl_str_mv |
Vaccine, ISSN:0264410X, 13588745, Vol.26, No.46 (2008); pp. 5864-5873 |
dc.relation.uri.spa.fl_str_mv |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-53449093079&doi=10.1016%2fj.vaccine.2008.08.014&partnerID=40&md5=f24cf4ad2c3fdb0f0fb8cc9ebd87a1a3 |
dc.rights.coar.fl_str_mv |
http://purl.org/coar/access_right/c_abf2 |
dc.rights.acceso.spa.fl_str_mv |
Abierto (Texto Completo) |
rights_invalid_str_mv |
Abierto (Texto Completo) http://purl.org/coar/access_right/c_abf2 |
dc.format.mimetype.none.fl_str_mv |
application/pdf |
institution |
Universidad del Rosario |
dc.source.instname.spa.fl_str_mv |
instname:Universidad del Rosario |
dc.source.reponame.spa.fl_str_mv |
reponame:Repositorio Institucional EdocUR |
repository.name.fl_str_mv |
Repositorio institucional EdocUR |
repository.mail.fl_str_mv |
edocur@urosario.edu.co |
_version_ |
1814167740299083776 |